Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen
通过生物报告药物筛选,鉴定出FDA批准的比福那唑是一种SARS-CoV-2阻断剂。
期刊:Molecular Therapy
影响因子:12.1
doi:10.1016/j.ymthe.2022.04.025
Zaid Taha ,Rozanne Arulanandam ,Glib Maznyi ,Elena Godbout ,Madalina E Carter-Timofte ,Naziia Kurmasheva ,Line S Reinert ,Andrew Chen ,Mathieu J F Crupi ,Stephen Boulton ,Geneviève Laroche ,Alexandra Phan ,Reza Rezaei ,Nouf Alluqmani ,Anna Jirovec ,Alexandra Acal ,Emily E F Fekete ,Ragunath Singaravelu ,Julia Petryk ,Manja Idorn ,Kyle G Potts ,Hayley Todesco ,Cini John ,Douglas J Mahoney ,Carolina S Ilkow ,Patrick Giguère ,Tommy Alain ,Marceline Côté ,Søren R Paludan ,David Olagnier ,John C Bell ,Taha Azad ,Jean-Simon Diallo